Laurence Verrièle

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a []GTPγS binding study

Adrian Newman‐Tancredi, Samantha Gavaudan, Caroline Conte et al. · European Journal of Pharmacology · 1998 · 226 citations

Molecular Pharmacology, Antagonist Actions, Antipsychotic Agents +8

Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor Subtypes

Adrian Newman‐Tancredi, Didier Cussac, Yann Quentric et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 192 citations

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites

Hervé Canton, Laurence Verrièle, Françis C. Colpaert · European Journal of Pharmacology · 1990 · 171 citations

5-Ht1c Sites, Psychiatry, Psychotic Disorder +11

Actions of α2 adrenoceptor ligands at α2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for α2A adrenoceptors

Adrian Newman‐Tancredi, Jean‐Paul Nicolas, Valérie Audinot et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1998 · 119 citations

Molecular Pharmacology, Medicine, α2 Adrenoceptor +8

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors

Adrian Newman‐Tancredi, C. Chaput, Laurence Verrièle et al. · Neuropharmacology · 1996 · 112 citations

Psychoactive Drug, Functional Selectivity, Medicine +5